Gene · 8607
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor suppressor BAP1 nuclear import is governed by transportin-1. | J Cell Biol | 2022 | 35446349 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Proteomics Approach Highlights Early Changes in Human Fibroblasts-Pancreatic Ductal Adenocarcinoma Cells Crosstalk. | Cells | 2022 | 35406724 | PubTator, text mining | PubMed |
| [Research progress of Fanconi anemia and DNA interstrand crosslink repair]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35381685 | PubTator, text mining | PubMed |
| Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis. | Exp Mol Med | 2022 | 35379935 | PubTator, text mining | PubMed |
| Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells. | BMC Pharmacol Toxicol | 2022 | 35366954 | PubTator, text mining | PubMed |
| Discovery of small-molecule inhibitors of RUVBL1/2 ATPase. | Bioorg Med Chem | 2022 | 35364523 | PubTator, text mining | PubMed |
| Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential. | Extracell Vesicles Circ Nucl Acids | 2022 | 35342902 | PubTator, text mining | PubMed |
| Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach. | Int J Mol Sci | 2022 | 35328380 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. | Biomolecules | 2022 | 35327559 | PubTator, text mining | PubMed |
| Gene Variants Involved in Nonsense-Mediated mRNA Decay Suggest a Role in Autism Spectrum Disorder. | Biomedicines | 2022 | 35327467 | PubTator, text mining | PubMed |
| A Systematic Review to Define the Multi-Faceted Role of Lysine Methyltransferase SETD7 in Cancer. | Cancers (Basel) | 2022 | 35326563 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma. | Front Cell Dev Biol | 2022 | 35252202 | PubTator, text mining | PubMed |
| A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases. | J Transl Autoimmun | 2022 | 35237749 | PubTator, text mining | PubMed |
| Metastasising Fibroblasts Show an HDAC6-Dependent Increase in Migration Speed and Loss of Directionality Linked to Major Changes in the Vimentin Interactome. | Int J Mol Sci | 2022 | 35216078 | PubTator, text mining | PubMed |
| Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry. | Front Mol Biosci | 2022 | 35211510 | PubTator, text mining | PubMed |
| Rap1 regulates TIP60 function during fate transition between two-cell-like and pluripotent states. | Genes Dev | 2022 | 35210222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/papers?page=16